Malaria Vaccination
-
{
- All
- News
- Videos
-
Oxford, Serum Institute Of India Join Forces For Next-Generation Malaria Vaccine
Oxford and Serum Institute of India have partnered to develop the R78C malaria vaccine. Experts say this next-generation shot could improve protection by targeting multiple stages of the parasite lifecycle.
-
How Vaccinations Play A Crucial Role In Malaria Prevention
Vaccinations play a crucial role in malaria prevention. Dr Neha Rastogi explains how vaccinations play a role in preventing the high disease burden of malaria.
-
Johns Hopkins Expert Warns Of Rising Malaria Threat Despite Vaccinations
According to WHO data, there were 282 million cases of malaria in 2024, an increase of about 9 million cases (3%) compared with 2023.
-
Top Scientific Discoveries Of 2025: A Year of Quantum Leaps And Cosmic Revelations
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and fundamental physics.
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
WHO Recommends Malaria Vaccine Made By Oxford University, Serum Institute
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.
-
"Now We Have Two": WHO Recommends 2nd Malaria Vaccine For Children
The World Health Organization said Monday that its experts had recommended a second malaria vaccine for children, R21/Matrix-M, developed by Britain's Oxford University.
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
Alphabet’s DeepMind Predicts Nearly All Protein Structures Known to Science
The AlphaFold software by Google’s DeepMind has predicted nearly all protein structures known to science. These have been stored in the AlphaFold DB for researchers to easily access.
-
World's 1st Malaria Shot Won't Reach Millions Of Children. Here's Why
After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute.
-
World's First Malaria Vaccine Approved By WHO
The World Health Organization on Wednesday endorsed the RTS,S/AS01 malaria vaccine for children, the first against the mosquito-borne disease that kills more than 400,000 a year.
-
Potential Breakthrough In Malaria Vaccine? New Jab Demonstrates 77 Percent Efficacy
Despite many vaccines tested over the years, this is the first to meet the required WHO’s required efficacy target.
-
Oxford, Serum Institute Of India Join Forces For Next-Generation Malaria Vaccine
Oxford and Serum Institute of India have partnered to develop the R78C malaria vaccine. Experts say this next-generation shot could improve protection by targeting multiple stages of the parasite lifecycle.
-
How Vaccinations Play A Crucial Role In Malaria Prevention
Vaccinations play a crucial role in malaria prevention. Dr Neha Rastogi explains how vaccinations play a role in preventing the high disease burden of malaria.
-
Johns Hopkins Expert Warns Of Rising Malaria Threat Despite Vaccinations
According to WHO data, there were 282 million cases of malaria in 2024, an increase of about 9 million cases (3%) compared with 2023.
-
Top Scientific Discoveries Of 2025: A Year of Quantum Leaps And Cosmic Revelations
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and fundamental physics.
-
"Really Hate Mosquitoes": At Davos, Adar Poonawalla Explains Vaccine Plans To NDTV
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic Forum (WEF) meeting in Davos.
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
-
Serum Institute Begins Shipments Of Malaria Vaccine 'R21/Matrix-M' To Africa
Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.
-
WHO Recommends Malaria Vaccine Made By Oxford University, Serum Institute
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.
-
"Now We Have Two": WHO Recommends 2nd Malaria Vaccine For Children
The World Health Organization said Monday that its experts had recommended a second malaria vaccine for children, R21/Matrix-M, developed by Britain's Oxford University.
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
Alphabet’s DeepMind Predicts Nearly All Protein Structures Known to Science
The AlphaFold software by Google’s DeepMind has predicted nearly all protein structures known to science. These have been stored in the AlphaFold DB for researchers to easily access.
-
World's 1st Malaria Shot Won't Reach Millions Of Children. Here's Why
After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute.
-
World's First Malaria Vaccine Approved By WHO
The World Health Organization on Wednesday endorsed the RTS,S/AS01 malaria vaccine for children, the first against the mosquito-borne disease that kills more than 400,000 a year.
-
Potential Breakthrough In Malaria Vaccine? New Jab Demonstrates 77 Percent Efficacy
Despite many vaccines tested over the years, this is the first to meet the required WHO’s required efficacy target.
